Morse Asset Management, Inc Bio Techne Corp Transaction History

Morse Asset Management, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$353.85 - $487.79 $1.77 Million - $2.44 Million	-4,998 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $108,107 - $124,439	237 Added 4.98%	4,998 $2.59 Million
Q3 2021 Nov 09, 2021	BUY	$444.87 - $538.88 $2.12 Million - $2.57 Million	4,761 New	4,761 $2.31 Million

581

154M

180K

189K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.79B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Morse Asset Management, Inc with notifications on news.